Ivax Corp.
Ivax announces tender offer for 4.5% convertible senior subordinated notes due 2008
Published in Law and Health Weekly, March 18th, 2006
The indenture governing the notes requires Ivax to make the offer as a result of the merger of Ivax with and into a wholly owned subsidiary of Teva and the related replacement of the board of Directors of Ivax.
Ivax is offering to purchase the notes for cash at a purchase price, per $1,000 principal amount, equal to 100% of the principal amount, together with $17.88 per $1,000 principal amount, representing accrued and unpaid cash interest to, but...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Dermisonics, Inc.
U-Strip maker applies for U.S. patent on Power-E Cell battery - Drug Safety
WHO convenes stakeholders to find global solutions to counterfeit drugs - EntreMed, Inc.
EntreMed receives U.S. patent for analogs of anticancer compound - Hana Biosciences
Hana Biosciences announces issuance of Talotrexin patent - Harvard University
Lower mammography surveillance is seen in elderly breast cancer survivors - Harvard University
Researchers detail new studies and findings in the area of HIV/AIDS vaccines - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
